Zurcher Kantonalbank (Zurich Cantonalbank) Eiger Bio Pharmaceuticals, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $28 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022
SELL
$3.84 - $9.74 $16,600 - $42,106
-4,323 Closed
0 $0
Q4 2021

Feb 01, 2022
SELL
$5.12 - $8.19 $2,288 - $3,660
-447 Reduced 9.37%
4,323 $22,000
Q3 2021

Nov 15, 2021
BUY
$6.68 - $9.1 $213 - $291
32 Added 0.68%
4,770 $32,000
Q2 2021

Jul 30, 2021
BUY
$7.82 - $9.23 $2,721 - $3,212
348 Added 7.93%
4,738 $40,000
Q1 2021

May 03, 2021
BUY
$8.44 - $12.66 $37,051 - $55,577
4,390 New
4,390 $39,000

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $496M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email